Detalles de la búsqueda
1.
Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
Acta Pharmaceutica Sinica B
; (6): 2655-2669, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-888878
2.
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-468147
3.
Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-469776
4.
An anti-SARS-CoV-2 non-neutralizing antibody with Fc-effector function defines a new NTD epitope and delays neuroinvasion and death in K18-hACE2 mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-459408
5.
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-454546
6.
Molecular basis for antiviral activity of pediatric neutralizing antibodies targeting SARS-CoV-2 Spike receptor binding domain
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-501708
Resultados
1 -
6
de 6
1
Próxima >
>>